BGC
Beutel, Goodman & Co’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10
| Closed | -$1K | – | 175 |
|
|
2025
Q1 | $1K | Sell |
10
-1,746,467
| -100% | -$175M | ﹤0.01% | 201 |
|
|
2024
Q4 | $267M | Buy |
1,746,477
+2,323
| +0.1% | +$355K | 1.45% | 35 |
|
|
2024
Q3 | $338M | Sell |
1,744,154
-3,290
| -0.2% | -$638K | 1.67% | 31 |
|
|
2024
Q2 | $405M | Buy |
1,747,444
+181,659
| +12% | +$42.1M | 2.15% | 15 |
|
|
2024
Q1 | $338M | Buy |
1,565,785
+570,329
| +57% | +$123M | 1.74% | 25 |
|
|
2023
Q4 | $258M | Sell |
995,456
-3,820
| -0.4% | -$989K | 1.37% | 37 |
|
|
2023
Q3 | $257M | Sell |
999,276
-70
| -0% | -$18K | 1.52% | 29 |
|
|
2023
Q2 | $285M | Buy |
999,346
+21,620
| +2% | +$6.16M | 1.6% | 26 |
|
|
2023
Q1 | $272M | Buy |
977,726
+22,830
| +2% | +$6.35M | 1.6% | 27 |
|
|
2022
Q4 | $264M | Sell |
954,896
-3,085
| -0.3% | -$854K | 1.6% | 24 |
|
|
2022
Q3 | $256M | Sell |
957,981
-8,205
| -0.8% | -$2.19M | 1.73% | 24 |
|
|
2022
Q2 | $197M | Buy |
966,186
+26,025
| +3% | +$5.31M | 1.22% | 34 |
|
|
2022
Q1 | $198M | Buy |
940,161
+26,625
| +3% | +$5.61M | 1.12% | 37 |
|
|
2021
Q4 | $219M | Buy |
913,536
+363,520
| +66% | +$87.2M | 1.25% | 34 |
|
|
2021
Q3 | $156M | Buy |
550,016
+415,883
| +310% | +$118M | 0.95% | 40 |
|
|
2021
Q2 | $46.4M | Sell |
134,133
-38,399
| -22% | -$13.3M | 0.28% | 52 |
|
|
2021
Q1 | $48.3M | Buy |
+172,532
| New | +$48.3M | 0.3% | 53 |
|